UnitedHealth Group stock slips to EUR 356.80 late in session
Published on 11/04/2026 at 16:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSInvestor risks remain central
- UnitedHealth Group highlights medical-cost management as a factor that can affect results.
- Healthcare regulation, Medicare developments, cybersecurity and litigation remain material risks.
- The company investor calendar lists no upcoming events.
UnitedHealth Group stock traded at EUR 356.80 on Lang & Schwarz at 16:41 CET on Wednesday, November 4, 2026. Compared with the EUR 370.00 quote in our 08:35 report, the stock was down 3.57 percent.
UnitedHealth Group's investor-relations page lists medical-cost management, healthcare regulation, Medicare-related developments, cybersecurity and litigation among factors that could affect results. The company investor-relations page also lists no upcoming events.
Risk factors remain in focus
For investors, the combination of medical-cost execution and regulatory exposure remains important for assessing the insurer's earnings outlook. The company also points to Medicare program developments and legal actions as potential sources of uncertainty.
The real-time quote of UnitedHealth Group stock provides the latest market indication.
For the broader US market, investors can follow the S&P 500.
More news and analyses on UnitedHealth Group stock remain available for investors tracking medical costs, regulation and company execution.
UnitedHealth Group stock facts
- Company: UnitedHealth Group
- ISIN: US91324P1021
- Trading venue: Lang & Schwarz
- Quote: EUR 356.80 at 16:41 CET on November 4, 2026
- Change since the morning report: Down 3.57 percent from EUR 370.00 at 08:32 CET
